| Stage | LLY | % of rev | LFVN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $24.4B | 100.00% | $42M | 100.00% | LLY ×575.70 |
| Gross profit | $20.5B | 83.88% | $33M | 77.97% | LLY +5.9pp |
| Operating income | $8.6B | 35.28% | $2M | 3.93% | LLY +31.3pp |
| Pre-tax income | $8.4B | 34.46% | $2M | 4.00% | LLY +30.5pp |
| Net income | $6.5B | 26.44% | $1M | 3.02% | LLY +23.4pp |
| Stage | LLY | LFVN | Gap · A − B |
|---|---|---|---|
| Revenue | $24.4B100.00% | $42M100.00% | LLY ×575.70 |
| Gross profit | 83.88%$20.5B | 77.97%$33M | LLY +5.9pp |
| Operating income | 35.28%$8.6B | 3.93%$2M | LLY +31.3pp |
| Pre-tax income | 34.46%$8.4B | 4.00%$2M | LLY +30.5pp |
| Net income |
| 26.44%$6.5B |
| 3.02%$1M |
| LLY +23.4pp |
No disclosed counterparties: LFVN.
None